Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).
Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Min Chul
http://orcid.org/0000-0003-4509-6731
MC
Choi
Center for Uterine Cancer, National Cancer Center, Goyang, Korea. gynlim@gmail.com.
Myong Cheol
http://orcid.org/0000-0001-8964-7158
MC
Lim
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Dong Hoon
http://orcid.org/0000-0002-4312-966X
DH
Suh
Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Yong Jung
http://orcid.org/0000-0002-6103-2466
YJ
Song
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Tae Joong
http://orcid.org/0000-0002-9693-9164
TJ
Kim
Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
Suk Joon
http://orcid.org/0000-0002-0558-0038
SJ
Chang
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
Jae Weon
http://orcid.org/0000-0003-1835-9436
JW
Kim
D005185:Fallopian Tube Neoplasms / Q000235:genetics*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D005820:Genetic Testing; D006801:Humans; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics*; D010534:Peritoneal Neoplasms / Q000235:genetics*; D056910:Republic of Korea; D012955:Societies, Medical